BDBM13530 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide::CHEMBL941::Gleevec::Imatinib::Imatinib, 21::N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide::STI-571::STI571::US10906896, Cpd imatinib::US11649218, Example Imatinib::US11725005, Compound imatinib::US9255107, Imatinib::cid_5291::imatinib-CD3::med.21724, Compound 6
SMILES CN1CCN(Cc2ccc(cc2)C(=O)Nc2ccc(C)c(Nc3nccc(n3)-c3cccnc3)c2)CC1
InChI Key InChIKey=KTUFNOKKBVMGRW-UHFFFAOYSA-N
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 13530
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Affinity DataKd: 520nMAssay Description:Kinase inhibitors are a new class of therapeutics with a propensity to inhibit multiple targets. The biological consequences of multi-kinase activity...More data for this Ligand-Target Pair
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Affinity DataKd: 520nMAssay Description:Binding constant for BLK kinase domainMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase Blk(Homo sapiens (Human))
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Genomics Institute of The Novartis Research Foundation
Curated by PDSP Ki Database
Affinity DataKd: 520nMAssay Description:Binding constant for BLK kinase domainMore data for this Ligand-Target Pair